Search results
AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View
Zacks via Yahoo Finance· 6 days agoSales from the neuroscience portfolio increased 16.0% to $1.97 billion, driven by higher sales of...
AbbVie Reports First-Quarter 2024 Financial Results
FOX 23 News Albany· 6 days agoTherapeutic Net Revenues Were $748 Million; Global Vraylar Net Revenues Were $694 Million; Combined Global Ubrelvy and Qulipta Net Revenues Were $334 MillionFirst-Quarter ...
AbbVie Is 'Firing On All Cylinders,' But Its Stock Doesn't Show That
Investor's Business Daily· 5 days agoAnalysts broadly predicted $765 million in sales, according to Raymond. His estimate was a more...
AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoAbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript April 26, 2024 AbbVie Inc. beats earnings...
7 Safe Haven Stocks That Can Withstand the Market's Worst Meltdowns
InvestorPlace· 1 day agoThe first one highlights the company’s leadership in digital services and advertising. Meanwhile,...
